Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.71 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 10/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.62 |
| ▸ | MAPT | P10636 | 9/20 | 0.62 |
| ▸ | POLB | P06746 | 6/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.62 |
| ▸ | THRB | P10828 | 3/20 | 0.62 |
| ▸ | S100A4 | P26447 | 2/20 | 0.62 |
| ▸ | NSD2 | O96028 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 5/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.60 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.60 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.60 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.59 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2481237 | 0.83 | ADORA2A (1.00) | CYP1A2ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL13295898 | 0.81 | CYP1A2 (0.67) | CYP1A2ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL12311502 | 0.78 | NR4A1 (0.79) | CYP1A2ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL14422840 | 0.77 | MAPT (1.00) | CYP1A2ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL13856162 | 0.75 | NR4A1 (1.00) | CYP1A2ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL12311433 | 0.75 | CYP1A2 (0.59) | CYP1A2ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL12311501 | 0.75 | NR4A1 (0.71) | CYP1A2ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL12311514 | 0.75 | NR4A1 (0.65) | CYP1A2ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL29384913 | 0.75 | NR4A1 (0.78) | CYP1A2ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL305199 | 0.75 | NR4A1 (0.78) | CYP1A2ADORA2AMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2057123-B1 | ANTHRAPYRIDONE COMPOUNDS | SABIC INNOVATIVE PLASTICS IP (NL) | 2011-10-19 | — | — | EP | disclosed |
| US-7812076-B2 | Anthrapyridone compounds | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-10-12 | — | — | US | disclosed |
| EP-2057123-A1 | ANTHRAPYRIDONE COMPOUNDS | Sabic Innovative Plastics IP B.V. (NL) | 2009-05-13 | — | — | EP | disclosed |
| US-20080045634-A1 | ANTHRAPYRIDONE COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 2008-02-21 | — | — | US | disclosed |
| WO-2008021694-A1 | ANTHRAPYRIDONE COMPOUNDS | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-02-21 | — | — | WO | disclosed |
| EP-1546263-B1 | ACID RED 82 IN MIXTURES | LANXESS DEUTSCHLAND GMBH (DE) | 2007-10-03 | — | — | EP | disclosed |
| EP-1546263-B1 | ACID RED 82 IN MIXTURES | LANXESS DEUTSCHLAND GMBH (DE) | 2007-10-03 | — | — | EP | disclosed |
| US-7193085-B2 | Acid Red 82 in mixtures | LANXESS DEUTSCHLAND GMBH (DE) | 2007-03-20 | — | — | US | disclosed |
| US-7193085-B2 | Acid Red 82 in mixtures | LANXESS DEUTSCHLAND GMBH (DE) | 2007-03-20 | — | — | US | disclosed |
| US-7193085-B2 | Acid Red 82 in mixtures | LANXESS DEUTSCHLAND GMBH (DE) | 2007-03-20 | — | — | US | disclosed |
| US-20060144289-A1 | Acid red 82 in mixtures | LANXESS DEUTSCHLAND GMBH (DE) | 2006-07-06 | — | — | US | disclosed |
| EP-1546263-A1 | ACID RED 82 IN MIXTURES | Lanxess Deutschland GmbH (DE) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004031301-A1 | ACID RED 82 IN MIXTURES | LANXESS DEUTSCHLAND GMBH (DE) | 2004-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060144289-A1 | Acid red 82 in mixtures | IK, CD74, ALDH1A2 | CYP1A2 39/4885ADORA2A 1863/4885MEN1 1723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.